Leah Akinseye
Pediatric Endocrinology · Memphis, TNNPI 1952781064
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (33.4%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. 36 manufacturers reported payments, led by Boehringer Ingelheim at 37.2% of the total. 2025 is the largest year on record at $11,135, more than ten times the $447 reported in 2022.
Across 177 payments — averaging $77.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$5K
- Biomarin Pharmaceutical Inc.$4K
- Novo Nordisk$654
- AbbVie$429
- Insulet Corporation$372
- Sequel Med Tech, LLC$352
- plus $2K from 30 others
What the payments were for
- Consulting fees$3,75027%
- Speaking & faculty fees$3,31524%
- Travel & lodging$2,11715%
- Food & beverage$4,59633%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 12 | $5,129 |
| Biomarin Pharmaceutical Inc. | 10 | $4,483 |
| Novo Nordisk | 26 | $654 |
| AbbVie | 19 | $429 |
| Insulet Corporation | 11 | $372 |
| Sequel Med Tech, LLC | 13 | $352 |
| Ascendis Pharma Endocrinology Inc | 9 | $240 |
| Xeris Pharmaceuticals, Inc. | 12 | $227 |
| AstraZeneca | 6 | $205 |
| Lilly USA, LLC | 4 | $182 |
| BETA Bionics, Inc. | 1 | $148 |
| Azurity Pharmaceuticals, Inc. | 6 | $146 |
| Corcept Therapeutics | 2 | $146 |
| Sanofi-aventis U.S. LLC | 7 | $137 |
| Pfizer | 6 | $129 |
| Kyowa Kirin, Inc. | 4 | $128 |
| Abbott | 2 | $116 |
| Recordati_rare_diseases_inc. | 3 | $61 |
| Chiesi USA, Inc. | 3 | $56 |
| Hologic Sales And Service, LLC | 2 | $51 |
| Radius Health, Inc. | 2 | $45 |
| Endo Pharmaceuticals Inc. | 2 | $38 |
| Cequr Corporation | 2 | $38 |
| Madrigal Pharmaceuticals | 1 | $30 |
| Rhythm Pharmaceuticals, Inc. | 1 | $25 |
| Neurocrine Biosciences, Inc. | 1 | $24 |
| Amryt Pharma Holdings Ltd | 1 | $23 |
| Antares Pharma, Inc. | 1 | $21 |
| Eton Pharmaceuticals, Inc. | 1 | $20 |
| Regeneron Healthcare Solutions, Inc. | 1 | $20 |
| Tandem Diabetes Care, Inc. | 1 | $19 |
| Endo USA, Inc. | 1 | $18 |
| GRT US Holding, Inc. | 1 | $17 |
| Soleno Therapeutics, Inc. | 1 | $17 |
| Arbor Pharmaceuticals, Inc. | 1 | $16 |
| Amneal Pharmaceuticals LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VOXZOGO 1.2mg$4,256
- iLet Bionic Pancreas$443
- Omnipod$217
- Lupron Depot$207
- Korlym$125
- SKYTROFA$104
- FreeStyle Libre$102
How this compares
$13,778 in reported general payments places this provider in the 80th percentile of 37 pediatric endocrinology providers in Tennessee.
Other pediatric endocrinology in Memphis
- Ana KarabellMemphis$14K
- Christine YuMemphis$4K
- Kathryn SumpterMemphis$1K
- Jordan RossMemphis$313
- Ramin AlemzadehMemphis$286
- Alicia Diaz-ThomasMemphis$124
- Ellen GrishmanMemphis$111
- Candice WalkerMemphis$28
- Justin GregoryNashville$254K
- Nidhi GuptaFranklin$157K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.